Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study.

BioDrugs · 2018 · PMC6290713 · PMID 30341487

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In January 2017, for the first time, biosimilar vials reached over 50% of overall vials distributed in the aforementioned Italian regions, with an increasing trend over the years (Fig. 1 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.